Abstract
Remoxipride, a new potential antipsychotic drug, was administered over 4 days at two dose levels, 70 and 140 mg t.i.d., to eight healthy male volunteers. Pharmacokinetics, safety, tolerability, and effect on plasma prolactin levels were evaluated. Remoxipride exhibited essentially linear pharmacokinetics. Only minor deviations in biochemical and physiological safety parameters were found. The drug was well tolerated by all subjects at the 70 mg dose level. At 140 mg akathisia appeared in seven subjects. The drug induced a rapid and transient increase in plasma prolactin concentrations at both dose levels after single doses. During steady state, a significant reduction in the prolactin response was observed as compared to after the first dose.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersson BG, Reher D, Cooper TB (1981) Prolonged adverse effects of haloperidol in normal subjects. N Engl J Med 305:643–644
Barnes TRE, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:874–878
Belmaker RH, Wald D (1979) Haloperidol in normals. Br J Psychiatry 131:222–223
Braude WM, Barnes TR, Gore SM (1983) Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry 143:139–150
Carlsson A, Lindqvist M (1963) Effects of chlorpromazine or haloperidol on formation of 3-methoxythyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144
Crane GE, Naranjo ER, Chase C (1971) Motor disorders induced by neuroleptics. A proposed new classification. Arch Gen Psychiatry 24:179–184
Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231:258–265
Farde L, Wiesel FA, Halldin C, Sedvall G (1988a) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71–76
Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G (1988 b) An open label trial of raclopride in acute schizophrenia-confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology 94:1–7
Florvall L, Persson ML, Ögren SO (1983) Potential neuroleptic agents 2. Synthesis and dopamine blocking activity of some new 2,6-dimethoxybenzamide derivatives. Acta Pharm Suec 20:365
Fuxe K, Ögren S-O, Fredholm B, Agnati L, Hökfelt T, Perez de la More M (1976) Possibilities of a differential blockade of central monoamine receptors. In: de Ajuriaguerra J, Tissot R (eds) Rhinencephale Neurotransmitteurs et Psychoses. Symposium Bel-Air Geneve
Hodge JR (1959) Akathisia: The syndrome of motor restlessness. Am J Psychiatry 116:337–338
Kekich WA (1978) Neuroleptics. JAMA 240:2185
Kendler KS (1976) A medical student's experience with akathisia. Am J Psychiatry 133:454–455
Peck RE (1959) The SHP-test — an aid in the detection and measurement of depression. Arch Gen Psychiatry 1:35–40
Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, beta-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137 (12):1518–1522
van Putten (1975) The many faces of akathisia. Compr Psychiatry 16:43–47
Sedvall G, Alfredsson G, Bjerkenstedt L, Eneroth P, Fyrö B, Härnryd C, Swahn CG, Wiesel FA, Wode-Helgodt B (1975) Selective effects of psychoactive drugs on levels of monoamine metabolites and prolactin in cerebrospinal fluid of psychiatric patients. In: Toumisto J, Parsonen MK (eds) Proceedings of the Sixth Int Congress of Pharmacology, vol 3, pp 255–267
Ögren SO, Hall H, Köhler K, Magnusson O, Lindbom LO, Agneby K, Florvall L (1983) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 192:459
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farde, L., Grind, M., Nilsson, MI. et al. Remoxipride — a new potential antipsychotic drug. Psychopharmacology 95, 157–161 (1988). https://doi.org/10.1007/BF00174501
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00174501